MCID: GST078
MIFTS: 39

Gastrointestinal Allergy

Categories: Immune diseases, Gastrointestinal diseases

Aliases & Classifications for Gastrointestinal Allergy

MalaCards integrated aliases for Gastrointestinal Allergy:

Name: Gastrointestinal Allergy 12 52 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:0060502

Summaries for Gastrointestinal Allergy

Disease Ontology : 12 A hypersensitivity reaction type I disease located in the gastrointestinal tract.

MalaCards based summary : Gastrointestinal Allergy is related to penis agenesis and enthesitis-related juvenile idiopathic arthritis. An important gene associated with Gastrointestinal Allergy is CCL11 (C-C Motif Chemokine Ligand 11), and among its related pathways/superpathways are Allograft rejection and Immune response Fc epsilon RI pathway. The drugs Citalopram and Reboxetine have been mentioned in the context of this disorder. Affiliated tissues include testes, colon and pancreas, and related phenotypes are hematopoietic system and immune system

Related Diseases for Gastrointestinal Allergy

Diseases related to Gastrointestinal Allergy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 134)
id Related Disease Score Top Affiliating Genes
1 penis agenesis 10.8 CCL11 IL5
2 enthesitis-related juvenile idiopathic arthritis 10.8 CCL11 ITGAE
3 solitary cyst of breast 10.7 CCL11 IL5
4 hidradenitis suppurativa 10.7 CCL11 CCL5
5 hypercementosis 10.7 CCL5 IL5
6 papillary follicular thyroid adenocarcinoma 10.6 IL5 RNASE3
7 toxic diffuse goiter 10.5 IL5 RNASE3
8 subacute bacterial endocarditis 10.5 IL5 RNASE3
9 psychotic disorder 10.5 CCL11 IL4
10 retinal vascular disease 10.5 CCL11 IL4
11 chronic cholangitis 10.5 CCL11 IL4
12 angioid streaks of choroid 10.5 IL4 IL5
13 allescheriosis 10.5 IL4 IL5
14 urethral intrinsic sphincter deficiency 10.5 IL4 IL5
15 signet ring cell adenocarcinoma 10.4 IL5 RNASE3
16 cherry allergy 10.4 IL4 IL5
17 skin disease 10.4 IL5 RNASE3
18 myofascial pain syndrome 10.4 CCL11 CCL5 IL5
19 collagenous gastritis 10.4 CMA1 RNASE3
20 histoplasmosis retinitis 10.4 IL4 IL5
21 abdominal tuberculosis 10.4 IL4 IL5
22 antley-bixler syndrome with genital anomalies and disordered steroidogenesis 10.4 CCL11 IL5 TSLP
23 glucose intolerance 10.4 IL4 IL5
24 conjunctival concretion 10.4 CCL11 IL5 TSLP
25 adenoid squamous cell carcinoma 10.4 CCL11 CCL5 IL5
26 lymphocytic gastritis 10.3 CCL11 IL5 RNASE3
27 drug psychosis 10.3 CCL11 CD79A
28 spindle cell variant squamous cell breast carcinoma 10.3 IL4 IL5
29 vascular dementia 10.3 CCL5 IL4
30 adrenal gland disease 10.3 CD79A ITGAE
31 inclusion conjunctivitis 10.3 CD79A IL5
32 dioctophymiasis 10.3 CCL11 IL4 IL5
33 epididymis adenocarcinoma 10.3 CCL11 IL4 IL5
34 fungal gastritis 10.3 CCL11 IL4 IL5
35 exophthalmos 10.3 CCL5 IL5 RNASE3
36 whistling face syndrome, recessive form 10.3 IL5 RNASE3
37 heart septal defect 10.2 CD79A RNASE3
38 chronic subinvolution of uterus 10.2 CCL5 CD79A
39 uveal epithelioid cell melanoma 10.2 CD79A RNASE3
40 acute necrotizing encephalopathy type 1 10.2 CCL5 IL5
41 solitary bone cyst 10.2 CD79A ITGAE
42 caplan's syndrome 10.2 AOC1 CD79A
43 pyridoxine deficiency 10.2 CD79A IL5
44 angioedema 10.2 AOC1 CMA1 RNASE3
45 cholesteatoma of middle ear 10.2 CCL11 CD79A IL5
46 diabetic angiopathy 10.2 CD79A IL4
47 dissociated nystagmus 10.2 IL4 IL5
48 aniseikonia 10.1 CD79A IL4
49 clostridium difficile colitis 10.1 CD79A RNASE3
50 polyneuropathy due to drug 10.1 CD79A IL4

Graphical network of the top 20 diseases related to Gastrointestinal Allergy:



Diseases related to Gastrointestinal Allergy

Symptoms & Phenotypes for Gastrointestinal Allergy

MGI Mouse Phenotypes related to Gastrointestinal Allergy:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.65 AOC1 CCL11 CCL5 CD79A CMA1 CRLF2
2 immune system MP:0005387 9.28 CCL11 CCL5 CD79A CMA1 CRLF2 IL4

Drugs & Therapeutics for Gastrointestinal Allergy

Drugs for Gastrointestinal Allergy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 821)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Citalopram Approved Phase 4,Phase 2 59729-33-8 2771
2
Reboxetine Approved, Investigational Phase 4 98769-81-4, 71620-89-8 123628 65856
3
Cyproheptadine Approved Phase 4,Phase 2,Early Phase 1 129-03-3 2913
4
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 75614-87-8, 51-45-6 774
5
Amoxicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3 26787-78-0 33613 2171
6
Ciprofloxacin Approved, Investigational Phase 4,Phase 2 85721-33-1 2764
7
Metronidazole Approved Phase 4,Phase 3,Phase 2,Phase 1 443-48-1 4173
8
Pancrelipase Approved Phase 4,Phase 2,Phase 1,Early Phase 1 53608-75-6
9
Budesonide Approved Phase 4,Phase 3,Phase 2 51333-22-3 63006 5281004
10
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1 170277-31-3
11
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 73590-58-6 4594
12
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
13
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
14
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1 331731-18-1 16219006
15
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 2 185243-69-0
16
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
17
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
18
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-02-2 5743
19
Glycerol Approved, Investigational Phase 4,Phase 2,Phase 1 56-81-5 753
20
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1 657-24-9 14219 4091
21
Pioglitazone Approved, Investigational Phase 4 111025-46-8 4829
22
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 1 50-78-2 2244
23
Vancomycin Approved Phase 4,Phase 2 1404-90-6 441141 14969
24
Erythromycin Approved, Vet_approved Phase 4,Phase 3,Phase 2 114-07-8 12560
25
Clarithromycin Approved Phase 4,Phase 2,Phase 3 81103-11-9 84029
26
Liraglutide Approved Phase 4 204656-20-2 44147092
27
Insulin Glargine Approved Phase 4 160337-95-1
28
Indomethacin Approved, Investigational Phase 4,Early Phase 1 53-86-1 3715
29
Dexlansoprazole Approved Phase 4,Phase 2,Phase 3 138530-94-6, 103577-45-3 9578005
30
Lansoprazole Approved, Investigational Phase 4,Phase 2,Phase 3 103577-45-3 3883
31
Montelukast Approved Phase 4,Phase 2 158966-92-8 5281040
32
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
33
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
34
Sunitinib Approved, Investigational Phase 4,Phase 2 341031-54-7, 557795-19-4 5329102
35
Orlistat Approved, Investigational Phase 4 96829-58-2 3034010
36
Clotrimazole Approved, Vet_approved Phase 4 23593-75-1 2812
37
Nystatin Approved, Vet_approved Phase 4 1400-61-9 11953884
38
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 104987-11-3 445643 439492
39
Mannitol Approved, Investigational Phase 4,Phase 1,Early Phase 1 69-65-8 453 6251
40
Celecoxib Approved, Investigational Phase 4,Phase 2,Phase 1 169590-42-5 2662
41
Ibuprofen Approved Phase 4 15687-27-1 3672
42
Naproxen Approved, Vet_approved Phase 4,Phase 1 22204-53-1 1302 156391
43
Magnesium oxide Approved Phase 4,Phase 3,Phase 2 1309-48-4 14792
44
Tadalafil Approved, Investigational Phase 4 171596-29-5 110635
45
Zinc Approved Phase 4,Phase 2,Phase 1,Early Phase 1 7440-66-6 32051 23994
46
Aripiprazole Approved, Investigational Phase 4,Phase 2,Phase 3 129722-12-9 60795
47
Olanzapine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 132539-06-1 4585
48
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
49
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
50
Risperidone Approved, Investigational Phase 4,Phase 2,Phase 3 106266-06-2 5073

Interventional clinical trials:

(show top 50) (show all 1072)

id Name Status NCT ID Phase Drugs
1 Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder Unknown status NCT00209807 Phase 4 escitalopram;Reboxetine
2 Manipulation of Visceral Sensitivity and Immune System in IBS Unknown status NCT00418340 Phase 4 probiotic (bacterial/dietary supplement)
3 Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects Unknown status NCT00258141 Phase 4 Rupatadine;Placebo
4 Preoperative Assessment of Colon Tumor Unknown status NCT00114829 Phase 4
5 Diverticulitis: Antibiotics or Close Observation? Unknown status NCT01111253 Phase 4 Amoxicillin-clavulanate
6 Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study Unknown status NCT01800734 Phase 4
7 Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis Unknown status NCT01846962 Phase 4 Budesonide;Fluticasone
8 Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis Unknown status NCT01282528 Phase 4
9 Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD) Unknown status NCT01822106 Phase 4
10 Long Term Tapering or Standard Steroids for Nephrotic Syndrome Unknown status NCT00308321 Phase 4 long term tapering of prednisolone;standard prednisolone treatment
11 Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker Unknown status NCT01072058 Phase 4 TNF blockers (infliximab, adalimumab, etanercept)
12 A Phase IV Trial of Neuroprotection With ACTH in Acute Optic Neuritis Unknown status NCT01838174 Phase 4 ACTHAR Gel (ACTH);IV steroids with oral taper
13 The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Sensitivity in Healthy Volunteers Completed NCT02674256 Phase 4 CRH
14 Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens Completed NCT00557284 Phase 4 Montelukast;Placebo
15 Pharmacogenetics of Gastrointestinal Bleeding Completed NCT00190255 Phase 4
16 Manipulation of Visceral Hypersensitivity With Probiotic Bacteria in Irritable Bowel Syndrome Completed NCT01139736 Phase 4
17 Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding Completed NCT00838864 Phase 4 ceftrioxone;ceftrioxone
18 Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients Completed NCT01402089 Phase 4 Sunitinib;Erlotinib;Midazolam;Caffeine
19 The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers Completed NCT02736734 Phase 4 CRH
20 Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat Completed NCT00991926 Phase 4 Orlistat
21 The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis Completed NCT01507766 Phase 4 early enteral nutrition;Delayed enteral nutrition
22 Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation Completed NCT00629122 Phase 4 Tacrolimus/Clotrimazole Troche;Tacrolimus/Nystatin Suspension
23 iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions Completed NCT02552537 Phase 4 Omeprazole;Placebo
24 Effects of Infliximab on Insulin Sensitivity and Beta Cell Function in Insulin Resistant Human Obesity Completed NCT00636142 Phase 4
25 Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen Completed NCT00346216 Phase 4 celecoxib;Ibuprofen;Naproxen
26 Effect of Tadalafil on Insulin Secretion and Insulin Sensitivity in Obese Men. Completed NCT02595684 Phase 4 Tadalafil;Placebo
27 Examining the Effects of Antipsychotic Medications on Insulin Sensitivity Completed NCT00895921 Phase 4 Olanzapine;Aripiprazole
28 Centocor Microarray Study of Patients Completed NCT00462072 Phase 4 Infliximab
29 Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes Completed NCT00338949 Phase 4 Ziprasidone;Standard atypical antipsychotic drug
30 Antitussive Effect of a Naturally Flavored Syrup Containing Diphenhydramine, Compared With Dextromethorphan and Placebo Completed NCT02062710 Phase 4 diphenhydramine/phenylephrine/cocoa; dextromethorophan; placebo;diphenhydramine/phenylephrine/cocoa; placebo; dextromethorphan;dextromethorphan; diphenhydramine/phenylephrine/cocoa; placebo;dextromethorophan; placebo; diphenhydramine/phenylephrine/cocoa;placebo; diphenhydramine/phenylephrine/cocoa; dextromethorphan;placebo; dextromethorphan; diphenhydramine/phenylephrine/cocoa
31 Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder Completed NCT00190749 Phase 4 olanzapine;risperidone
32 Irritable Bowel Syndrome (IBS) Treatment With H1-receptor Antagonists Completed NCT01144832 Phase 4 ebastine;placebo capsule
33 Magnetic Resonance (MR) Colonography With Fecal Tagging Completed NCT00114842 Phase 4
34 Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis Completed NCT01119287 Phase 4 Dexamethasone 0.1% ophthalmic suspension;Olopatadine hydrochloride 0.1% ophthalmic solution
35 Diagnostic Accuracy of Capsule Endoscopy in Small Bowel Crohn's Disease Completed NCT00588653 Phase 4
36 Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms Completed NCT00938704 Phase 4 carboxymethylcellulose 0.5% +glycerin 0.9%;sodium hyaluronate 0.18%
37 To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses Completed NCT00648973 Phase 4 Diphenhydramine 50 mg;Diphenhydramine 25 mg;Pseudoephedrine 120 mg
38 Dexmedetomidine Versus Placebo in Endoscopic Retrograde Cholangiopancreatography (ERCP) Sedation Completed NCT01070680 Phase 4 Precedex;sodium chlorid 0,9%
39 Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD) Completed NCT02805907 Phase 4 Calcifediol;Placebo
40 Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics Completed NCT01411930 Phase 4 Intramuscular olanzapine, aripiprazole;Intramuscular aripiprazole, olanzapine
41 Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole Completed NCT00205660 Phase 4 ziprasidone;risperidone;olanzapine;quetiapine;aripiprazole;aripiprazole;aripiprazole;aripiprazole
42 Tdap Vaccine in Post-Partum Women Completed NCT01711645 Phase 4
43 MR Colonography With Fecal Tagging. Barium vs. BariumFerumoxsil Completed NCT00332943 Phase 4
44 Anti-TNF Agents for the Treatment of Rheumatoid Arthritis Completed NCT00837434 Phase 4 Etanercept;Adalimumab
45 Appendicectomy Skin Closure Technique: Changing Paradigms (ASC) Completed NCT02625987 Phase 4
46 Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea Completed NCT01195090 Phase 4 Sitagliptin;pioglitazone
47 Medical Polypectomy and Predictors of Response Completed NCT00788749 Phase 4 Prednisolone;Placebo
48 Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis Completed NCT00432406 Phase 4 Infliximab;Etanercept
49 Curcumin (Tumeric) in the Treatment of Irritable Bowel Syndrome: A Randomized-Controlled Trial Completed NCT00779493 Phase 4
50 The Effect of Dexamethasone Added to Bupivacain in Nasal Surgery Completed NCT03036605 Phase 4 Bupivacaine;Dexamethasone

Search NIH Clinical Center for Gastrointestinal Allergy

Genetic Tests for Gastrointestinal Allergy

Anatomical Context for Gastrointestinal Allergy

MalaCards organs/tissues related to Gastrointestinal Allergy:

39
Testes, Colon, Pancreas, Prostate, Kidney, Breast, Liver

Publications for Gastrointestinal Allergy

Articles related to Gastrointestinal Allergy:

(show all 22)
id Title Authors Year
1
Effect of raw milk on allergic responses in a murine model of gastrointestinal allergy. ( 24870507 )
2014
2
Dietary elimination of children with food protein induced gastrointestinal allergy - micronutrient adequacy with and without a hypoallergenic formula? ( 25328667 )
2014
3
Guidance for the nutrition management of gastrointestinal allergy in pediatrics. ( 24565537 )
2013
4
Thymic stromal lymphopoietin is required for gastrointestinal allergy but not oral tolerance. ( 20600023 )
2010
5
Experimental gastrointestinal allergy enhances pulmonary responses to specific and unrelated allergens. ( 16890767 )
2006
6
Gastrointestinal allergy in adults. ( 16292080 )
2005
7
Revisiting the "hygiene hypothesis" in gastrointestinal allergy. ( 17033352 )
2002
8
Gastrointestinal allergy: clinical symptoms and immunological mechanisms. ( 11380898 )
2001
9
A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. ( 10841566 )
2000
10
The involvement of the histamine degradation pathway by diamine oxidase in manifest gastrointestinal allergies. ( 10350171 )
1999
11
Anti-schistosomal IgE and its relation to gastrointestinal allergy in breast-fed infants of Schistosoma mansoni infected mothers. ( 9707682 )
1998
12
Gastrointestinal allergy to food: a review. ( 9661317 )
1997
13
Analysis and characteristics of mast cell tryptase and eosinophilic cationic protein from human gut mucosa in gastrointestinal allergy. ( 8813193 )
1996
14
Gastrointestinal allergy. ( 7975041 )
1994
15
Food allergens as causative factors of respiratory, skin and gastrointestinal allergy confirmed by skin prick test and specific IgE and IgG4 FAST in children. ( 1292838 )
1992
16
Malrotation in children with symptoms of gastrointestinal allergy and psychosomatic abdominal pain. ( 3993380 )
1985
17
Childhood gastrointestinal allergy: forbidden fruits. ( 6902927 )
1980
18
Cromolyn in combined gastrointestinal allergy. ( 6771419 )
1980
19
Gastrointestinal allergy to soyabean protein in preruminant calves. Allergenic constituents of soyabean products. ( 575571 )
1979
20
Gastrointestinal allergy to soyabean protein in preruminant calves. Antibody production and digestive disturbances in calves fed heated soyabean flour. ( 575570 )
1979
21
Use of cromolyn in combined gastrointestinal allergy. ( 112265 )
1979
22
Protein-losing enteropathy associated with gastrointestinal allergy. ( 4168025 )
1967

Variations for Gastrointestinal Allergy

Expression for Gastrointestinal Allergy

Search GEO for disease gene expression data for Gastrointestinal Allergy.

Pathways for Gastrointestinal Allergy

Pathways related to Gastrointestinal Allergy according to GeneCards Suite gene sharing:

(show all 17)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.58 CCL11 IL4 IL5 RNASE3
2
Show member pathways
12.31 CD79A IGHE IL4 IL5
3
Show member pathways
12.08 CCL11 IL4 IL5
4
Show member pathways
11.91 CRLF2 IL4 IL5 TSLP
5 11.75 CD79A IL4 IL5
6 11.73 CCL11 IGHE IL4
7 11.45 IL4 IL5 ITGAE
8 11.36 CCL11 IGHE IL4 IL5
9 11.26 CRLF2 IL4 IL5 ITGAE TSLP
10 11.13 CCL11 CRLF2 IL4 IL5
11 11.08 IL4 IL5
12 11.02 IL4 IL5
13 11 IL4 IL5 TSLP
14 10.94 IL4 IL5
15 10.94 CCL11 CCL5 IL4 IL5
16 10.82 CCL11 CCL5 CMA1 IL4 IL5
17 10.63 IL4 IL5

GO Terms for Gastrointestinal Allergy

Cellular components related to Gastrointestinal Allergy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.5 AOC1 CCL11 CCL5 IL4 IL5 RNASE3
2 external side of plasma membrane GO:0009897 9.46 CD79A IGHE IL4 ITGAE
3 extracellular region GO:0005576 9.32 AOC1 CCL11 CCL5 CMA1 CRLF2 IGHE

Biological processes related to Gastrointestinal Allergy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 chemotaxis GO:0006935 9.5 CCL11 CCL5 IL4
2 B cell activation GO:0042113 9.37 CD79A IL4
3 innate immune response in mucosa GO:0002227 9.26 IL4 RNASE3
4 positive regulation of JAK-STAT cascade GO:0046427 9.16 CCL5 IL5
5 immune response GO:0006955 9.02 CCL11 CCL5 IGHE IL4 IL5
6 eosinophil chemotaxis GO:0048245 8.96 CCL11 CCL5

Molecular functions related to Gastrointestinal Allergy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.02 CCL11 CCL5 IL4 IL5 TSLP

Sources for Gastrointestinal Allergy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....